Orange Book product · Generic (ANDA)
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
At a glance
Oct 28, 2024
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 28, 2024
1 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
DOXYCYCLINE HYCLATE
Strength
EQ 100MG BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 218053
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DOXYCYCLINE HYCLATE
- 2016ACTICLATE CAPBrand (NDA)
NDA 208253 · CHARTWELL RX
- 2001DORYXBrand (NDA)
NDA 050582 · MAYNE PHARMA
- 1998PERIOSTATBrand (NDA)
NDA 050744 · COLLAGENEX
- —VIBRAMYCINBrand (NDA)
NDA 050007 · PFIZER
- 2026DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 203276 · AVET LIFESCIENCES
- 2025DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 211137 · MACLEODS PHARMS LTD
- 2025DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 218888 · ASPIRO
- 2025DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 218753 · DR REDDYS
- 2025DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217078 · PRECISION DOSE INC
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217487 · AMNEAL
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217854 · HERITAGE
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217794 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
